Stifel Financial’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.36M | Sell |
785,034
-4,628
| -0.6% | -$43.4K | 0.01% | 1043 |
|
|
2025
Q1 | $5.61M | Buy |
789,662
+391,901
| +99% | +$2.79M | 0.01% | 1124 |
|
|
2024
Q4 | $4.64M | Buy |
397,761
+303,151
| +320% | +$3.53M | ﹤0.01% | 1247 |
|
|
2024
Q3 | $1.94M | Buy |
94,610
+3,102
| +3% | +$63.7K | ﹤0.01% | 1794 |
|
|
2024
Q2 | $2.05M | Buy |
91,508
+7,416
| +9% | +$166K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $2.31M | Buy |
84,092
+15,569
| +23% | +$428K | ﹤0.01% | 1615 |
|
|
2023
Q4 | $2.09M | Buy |
68,523
+18,734
| +38% | +$571K | ﹤0.01% | 1639 |
|
|
2023
Q3 | $1.57M | Buy |
49,789
+6,387
| +15% | +$202K | ﹤0.01% | 1753 |
|
|
2023
Q2 | $1.77M | Buy |
43,402
+12,617
| +41% | +$515K | ﹤0.01% | 1715 |
|
|
2023
Q1 | $1.15M | Buy |
30,785
+430
| +1% | +$16K | ﹤0.01% | 1954 |
|
|
2022
Q4 | $1.06M | Buy |
30,355
+5,070
| +20% | +$177K | ﹤0.01% | 1962 |
|
|
2022
Q3 | $1.42M | Buy |
25,285
+1,028
| +4% | +$57.5K | ﹤0.01% | 1702 |
|
|
2022
Q2 | $1.26M | Buy |
24,257
+6,088
| +34% | +$315K | ﹤0.01% | 1827 |
|
|
2022
Q1 | $1.32M | Sell |
18,169
-1,605
| -8% | -$117K | ﹤0.01% | 1920 |
|
|
2021
Q4 | $2.34M | Sell |
19,774
-349
| -2% | -$41.3K | ﹤0.01% | 1501 |
|
|
2021
Q3 | $2.7M | Sell |
20,123
-3,213
| -14% | -$431K | ﹤0.01% | 1378 |
|
|
2021
Q2 | $3.78M | Sell |
23,336
-5,201
| -18% | -$842K | 0.01% | 1173 |
|
|
2021
Q1 | $2.29M | Buy |
28,537
+10,477
| +58% | +$841K | ﹤0.01% | 1438 |
|
|
2020
Q4 | $982K | Buy |
+18,060
| New | +$982K | ﹤0.01% | 1855 |
|
|
2018
Q4 | – | Sell |
-8,125
| Closed | -$234K | – | 2768 |
|
|
2018
Q3 | $234K | Buy |
+8,125
| New | +$234K | ﹤0.01% | 2490 |
|